Noorik Biopharmaceuticals AG
ActiveLimited or Corporation721001 - Research and experimental development in the pharmaceutical industrynoorik.com
Pharmaceuticals / BiopharmaceuticalsHealthcare providers, clinical researchers, and solid-organ transplant patients.
Noorik Biopharmaceuticals AG is a Swiss AG registered in Basel, BS. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~1-50 employees (specifically noted as 2 employees in some sources)RevenueUSD 3,000,000Officers7Active Relations5Deleted Relations0SOGC Records23First Record13.09.2010Latest Activity21.08.2026biopharmaceuticalscancer treatmenttumor microenvironmentdrug-developmentpharmabiotechnologynephrology
Registry Information
- Swiss UID
- CHE-115.986.883
- Legal Name
- Noorik Biopharmaceuticals AG
- Legal Form
- Limited or Corporation
- Incorporated
- 13 Sept 2010
- Share Capital
- CHF 189'123.50
- Canton
- BS
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
Lange Gasse 15
4052, Basel, BS
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Healthcare providers, clinical researchers, and solid-organ transplant patients.
Competitors (1)
Cipla, UCB, Biogen, Genentech, Bristol-Myers Squibb, Lilly, Vicore Pharma, Ability Pharma
Pharmaceutical companies listed include Cipla, UCB, Biogen, Genentech, Bristol-Myers Squibb, Lilly, and others.
Sources (7)
Noorik Biopharmaceuticals AG
noorik.com
Federal government signs four contracts for the development of COVID-19 medicines
admin.ch
Noorik Biopharmaceuticals AG | MTEC
mtec-sc.org
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome (NCT06256432)
clinicaltrials.gov
USE OF AMBRISENTAN FOR THE TREATMENT OF PORTAL HYPERTENSION AND CIRRHOSIS - Patent 3639827
data.epo.org
About
noorik.plateastudio.com
EP About this file - European Patent Register
register.epo.org